Single-chain Fc polypeptide univalent binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing univalent antibody fragments are impractical due to low yields and complex procedures, such as proteolytic cleavage or hybrid protein dimerization, which hinder large-scale production and efficient targeting of cell surface antigens without causing co-stimulation or antigenic modulation.

Innovation Solution

A single-chain polypeptide comprising two CH2 and two CH3 domains that form a functional Fc domain within the chain, linked by suitable amino acid sequences, allowing for recombinant production and monovalent binding without dimerization, enabling efficient targeting and effector functions like complement fixation and receptor binding.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If proteolytic cleavage is used to produce univalent antibody fragments, then the fragments retain natural effector functions, but the production yield is low and the procedure is complex

Engineering Contradiction:
Improveeffector function retentionVSAvoidproduction yield
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The antibody molecule is segmented into separate domains (Fc and variable regions) that are genetically fused to create a single-chain polypeptide. This segmentation allows the Fc domain to be separated from the need for proteolytic processing while retaining effector functions, and enables direct recombinant expression of the functional fragment without complex cleavage procedures.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A linker peptide acts as an intermediary element connecting the Fc domain to the variable region in the single-chain polypeptide. This intermediary allows the two functional domains to be genetically fused while maintaining their individual functions, eliminating the need for proteolytic cleavage and enabling high-yield recombinant production.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Strength

If bivalent antibodies are used for targeting cell surface antigens, then binding affinity is enhanced, but co-stimulation and antigenic modulation occur causing cell evasion

Engineering Contradiction:
Improvebinding affinityVSAvoidco-stimulation and antigenic modulation
Core Design Contradiction:
StrengthVSObject-affected harmful factors

Solution Approach 1:

The variable region responsible for antigen binding is extracted and genetically fused to the Fc domain in a single-chain configuration. This extraction creates a univalent binding structure that maintains affinity while preventing the cross-linking and co-stimulation effects caused by bivalent antibodies, thereby eliminating cell evasion mechanisms.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

Instead of using the traditional bivalent antibody structure with two separate Fab arms, the invention inverts the approach by creating a single-chain polypeptide with a single variable region fused to Fc. This inversion changes the valency from bivalent to univalent, preventing harmful co-stimulation while maintaining target binding capability.

Inventive Principle:
Principle #13The other way round (Inversion)

3Reliability

If univalent antibody fragments are produced by traditional methods, then antigenic modulation is avoided, but the production process is costly and time-consuming

Engineering Contradiction:
Improveavoidance of antigenic modulationVSAvoidpreparation time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The Fc domain and variable region are preliminarily connected through genetic fusion to form a single-chain polypeptide that is directly expressed as a functional univalent fragment. This preliminary action eliminates the need for subsequent proteolytic cleavage and purification steps, dramatically reducing preparation time and cost while maintaining the univalent structure that avoids antigenic modulation.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The single-chain polypeptide is designed to self-assemble into the functional univalent fragment structure through its intrinsic domain architecture. The Fc domain and variable region automatically fold and function together without requiring external proteolytic processing, enabling direct recombinant production and eliminating time-consuming preparation steps.

Inventive Principle:
Principle #25Self-service

Data Source

PatentEP3009448B1Single chain fc polypeptides
Publication Date: 2017.09.13 UCB BIOPHARMA SPRL
  • EP3009448B1 patent drawingFigure 1a~1c
  • EP3009448B1 patent drawingFigure 2a~2c
  • EP3009448B1 patent drawingFigure 3a~3c

AI summary

The present invention relates to single chain polypeptides comprising one or more immunoglobulin Fc domains. In particular the present invention relates to single-chain Fc polypeptides in which at least one functional Fc domain is formed within the polypeptide chain.